John Reneau

TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo

Ryang Hwa Lee, Ji Min Yu, Andrea M. Foskett et al. · Proceedings of the National Academy of Sciences · 2014 · 191 citations · Full text

Veterinary Medicine, Biomedical Sciences, Cell Biology +13

Preactivation of Human MSCs with TNF-α Enhances Tumor-Suppressive Activity

Ryang Hwa Lee, Nara Yoon, John Reneau et al. · Cell stem cell · 2012 · 121 citations · Full text

Medicine, Immunology, Oncology +14

BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis

Vijaya Bharti, Reese Watkins, Amrendra Kumar et al. · Cell Reports · 2022 · 49 citations · Full text

Medicine, Cancer Biology, Oncology +14

GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms

Xiangrong Geng, Chenguang Wang, Xin Gao et al. · Blood Cancer Journal · 2022 · 32 citations · Full text

Medicine, Immunology, Oncology +10

Preliminary Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Large Granular Lymphocytic Leukemia, and Solid Tumors

Aditi Shastri, Eric J. Feldman, Alexander Starodub et al. · Blood · 2023 · 18 citations

Pharmacy, Oncology, Pharmacokinetics +16